Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Apr 8 2016

Full Issue

Final Medicare Advantage Rates Involve Variety Of Compromises

Analysts say the new rates don't represent a loss or a gain for industry -- but rather a mixed bag.

Modern Healthcare: Final Medicare Advantage Rate Policies A Mixed Bag For Insurers

Did the Obama administration indulge health insurance companies with friendly changes to Medicare Advantage rate policies for 2017? Or did CMS officials stick to their guns on proposals the industry aggressively lobbied to kill? Experts say it was a little of both. “It embodies the definition of compromise,” said John Gorman, a Washington-based Medicare Advantage consultant and former CMS official. “Everybody goes home pissed.”David Windley, an equities analyst at Jefferies who tracks insurers, said it wasn't a loss for the industry, but he wouldn't call it a win either. “Maybe it's a save,” he said. And the lengthy April 4 policy document doesn't even tell the entire story. (Herman, 4/7)

Morning Consult: Allyson Schwartz Is Medicare Advantage’s Ambassador

Medicare Advantage, a private insurer alternative to Medicare, typically makes it onto Washington’s policymaking radar for about two months in the spring each year. That’s when the Centers for Medicare and Medicaid Services issues new MA plan rates and policies for the next year. Former Rep. Allyson Schwartz (D-Pa.) is trying to change that. She believes Medicare Advantage should be in the healthcare conversation year-round. As head of the relatively new nonpartisan MA advocacy group, Better Medicare Alliance, she intends to make that happen. (Owens, 4/7)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, July 15
  • Tuesday, July 14
  • Monday, July 13
  • Friday, July 10
  • Thursday, July 9
  • Wednesday, July 8
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF